VERVE-201 clinical trials

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

This study is testing a new treatment, VERVE-201, for people with very high cholesterol and fats in their blood that haven't responded to other medicines. Scientists want to see if it's safe and how it affects these blood fats by altering a specific gene in the liver.